Open an account

HCW Biologics

HCWB · NASDAQ

$1.17−$0.06 (−4.88%)TodayMarket closed ·
Prev close $1.23

About HCWB

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The company is headquartered in Miramar, Florida and currently employs 25 full-time employees. The company went IPO on 2021-07-20. The company is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. The company has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The firm is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.

Employees
36
Headquarters
Miramar, Florida
Listed
Jul 20, 2021
Sector
Health Care
Industry
Biotechnology
Website
hcwbiologics.com

HCWB key statistics

Market cap
2.62M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
868.87K
Volume
98.38K
Open price
$1.24
High today
$1.27
Low today
$1.17
52 Week high
$25.44
52 Week low
$1.14

HCW Biologics (HCWB) at a glance

As of Oct 20, 2026, HCW Biologics (HCWB) shares are priced at $1.17, giving the company a market cap of 2.62M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.17 and $1.27. The current price is 0.0% above the day's low and 7.9% below its high.

Volume so far is 98.38K shares, below the average of 868.87K shares a day.

Over the past year HCW Biologics has ranged from $1.14 to $25.44, and now sits 0% of the way up that range.

HCW Biologics met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$10.11 per share against an estimate of -$2.02.

The average analyst price target is $30.60, 2515.4% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 3 analystsAvg $30.60
Low
$30.30
Now
$1.17
High
$31.50

HCWB earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 98.2% on average.

  1. Q3 FY23: reported -$33.60 per share against an estimate of -$31.82
  2. Q4 FY23: reported -$72.00 per share against an estimate of -$34.27
  3. Q4 FY24: reported -$19.20 per share against an estimate of $22.03
  4. Q2 FY25: reported -$6.48 per share against an estimate of $11.02
  5. Q3 FY25: reported -$12.12 per share against an estimate of -$14.08
  6. Q4 FY25: reported -$18.36 per share against an estimate of -$5.14
  7. Q1 FY26: reported $2.22 per share against an estimate of -$2.69
  8. Q2 FY26: reported -$10.11 per share against an estimate of -$2.02

HCWB news

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Kaustubh Bagalkote

    Why Is HCW Biologics Stock Surging On Friday?

  • Kaustubh Bagalkote

    Why HCW Biologics Stock Is Surging On Thursday?

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Nabaparna Bhattacharya

    Why Is HCW Biologics Stock Gaining Today?

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • Avi Kapoor

    Crude Oil Surges 3%; RBC Bearings Earnings Top Views

Similar companies

Companies in the same industry as HCW Biologics

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.